IRIS
ULIVELLI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.091
EU - Europa 5.479
AS - Asia 915
AF - Africa 49
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
Totale 12.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.061
GB - Regno Unito 1.933
IE - Irlanda 921
IT - Italia 613
CN - Cina 522
SE - Svezia 499
UA - Ucraina 442
RU - Federazione Russa 358
FR - Francia 253
DE - Germania 219
SG - Singapore 210
FI - Finlandia 124
VN - Vietnam 63
TR - Turchia 59
CI - Costa d'Avorio 44
ES - Italia 33
CA - Canada 25
BE - Belgio 23
IN - India 17
HK - Hong Kong 12
AT - Austria 11
AU - Australia 10
NL - Olanda 10
CZ - Repubblica Ceca 8
EU - Europa 7
GR - Grecia 7
IL - Israele 5
BR - Brasile 4
MN - Mongolia 4
PK - Pakistan 4
PL - Polonia 4
RO - Romania 4
IR - Iran 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
CO - Colombia 2
JP - Giappone 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.562
Salva come PNG Salva come JPEG
Città #
Southend 1.830
Fairfield 976
Dublin 910
Chandler 522
Ashburn 509
Woodbridge 452
Wilmington 393
Jacksonville 364
Cambridge 340
Seattle 336
Houston 333
Ann Arbor 243
Santa Clara 223
Siena 198
Singapore 160
Princeton 159
Menlo Park 138
Beijing 117
Nanjing 113
Dong Ket 61
Helsinki 61
San Diego 60
Boardman 59
San Mateo 55
Dearborn 50
Abidjan 44
Nanchang 44
Izmir 40
Norwalk 37
Moscow 34
Florence 33
Shanghai 32
Málaga 31
New York 28
Tianjin 28
Shenyang 27
London 24
Brussels 23
Milan 23
Triggiano 20
Jinan 19
Fremont 18
Changsha 17
Rome 17
Düsseldorf 15
Kunming 15
Ottawa 13
Jiaxing 12
Hebei 11
Vienna 11
Zhengzhou 11
Guangzhou 10
Kilburn 10
San Francisco 10
Washington 10
Cisano Bergamasco 9
Los Angeles 9
Hangzhou 8
Ningbo 8
Berlin 7
Lappeenranta 7
Pune 7
Toronto 7
Arezzo 6
Falls Church 6
Pisa 6
Tappahannock 6
Brno 5
Carpi 5
Columbus 5
Edinburgh 5
Hefei 5
Lanzhou 5
Livorno 5
Monte 5
Pistoia 5
Redwood City 5
Sacramento 5
Turin 5
Amsterdam 4
Anguillara Sabazia 4
Ankara 4
Cedar Knolls 4
Central 4
Hong Kong 4
Islington 4
Monte San Savino 4
Munich 4
Sergnano 4
Ulan Bator 4
Verona 4
Villacidro 4
Bitonto 3
Boston 3
Canberra 3
Chiswick 3
Delhi 3
Figline Valdarno 3
Flero 3
Fort Worth 3
Totale 9.551
Salva come PNG Salva come JPEG
Nome #
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 244
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 234
Multiple sclerosis incidence in Tuscany from administrative data 219
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 211
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 209
Multiple sclerosis spatial cluster in Tuscany 206
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 194
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 189
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 188
Multiple sclerosis incidence in Tuscany from administrative data 186
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 184
The Italian Multiple Sclerosis Register 180
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 178
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 171
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 169
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 166
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 166
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 162
Increasing prevalence of multiple sclerosis in Tuscany, Italy 162
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 158
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 156
A clinically silent, but severe, duodenal complication of duodopa infusion 151
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 151
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 150
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 149
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 149
Antiparkinsonian drugs and visual hallucinations 148
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 146
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 145
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 143
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 143
The olfactory side of Parkinson disease: Relevance for clinical practice 141
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 139
Reliability of administrative data for the identification of Parkinson's disease cohorts 138
Citalopram as treatment of depression in patients with epilepsy 136
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 136
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 135
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 135
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 135
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 134
The heart side of brain neuromodulation 133
Clinical evidence of fluconazole-induced carbamazepine toxicity 131
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 130
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 129
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 129
Distinct olfactory cross-modal effects on the human motor system 129
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 129
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 129
Primary intraventricular haemorrhage in adults 129
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 128
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 126
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 126
Temporal dynamics of memory trace formation in the human prefrontal cortex 126
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 126
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 125
Seizures after spontaneous supratentorial intracerebral hemorrhage 124
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 123
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 122
La distribuzione geografica della sclerosi multipla in Toscana 122
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 121
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 118
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 118
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 118
Feasibility of TMS in patients with new generation cochlear implants 116
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 115
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 113
Somatosensory processing during movement observation in humans 113
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 113
Mortality of Parkinson’s disease in Italy from 1980 to 2015 113
null 112
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 112
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 111
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 110
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 109
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 108
null 106
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 104
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 102
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 99
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 99
Association of celiac disease in patients with multiple sclerosis in Tuscany 93
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 87
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 86
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 86
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 82
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 80
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 79
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 76
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 74
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 72
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 69
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 64
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 61
Pisa syndrome in Parkinson disease 58
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 47
Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders 44
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 35
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 33
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 32
Sars-CoV2 infection in pregnant women with multiple sclerosis 31
Totale 12.671
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.497 0 0 0 0 154 225 216 326 212 170 66 128
2020/20212.096 92 189 57 186 126 228 173 289 227 170 181 178
2021/20221.480 97 179 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.408 64 27 116 82 42 362 485 55 13 21 43 98
2024/2025956 57 163 271 174 291 0 0 0 0 0 0 0
Totale 12.847